Evidence map›Paper›PMID 40333252›Full record

ArticleVaccines2025

A Bioconjugate Vaccine Against Extra-Intestinal Pathogenic

Linhui Hao, Wenhua Huang, Yan Guo, Xiankai Liu, Jun Wu, Li Zhu, Chao Pan, Hengliang Wang

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The possibility of Escherichia coli transmission from pregnant women to the neonates.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Linhui HaoLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing 100071, China.
Wenhua HuangState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing 100071, China.ORCID 0000-0003-4687-2755
Yan GuoLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing 100071, China.
Xiankai LiuLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing 100071, China.
Jun WuLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing 100071, China.
Li ZhuLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing 100071, China.ORCID 0000-0001-9975-8978
Chao PanLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing 100071, China.
Hengliang WangState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing 100071, China.ORCID 0000-0001-8476-4320

Funding

Beijing Nova Program 20240484724National Key Research and Development Project of China 2021YFC2102100National Natural Science Foundation of China 92478116
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bioconjugate vaccinecholera toxin B subunit (CTB)extra-intestinal pathogenic Escherichia coli (ExPEC)protein glycan coupling technology (PGCT)

Identifiers

PMID40333252
PMCPMC12031530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.